Bausch Health Companies Inc.
https://www.bauschhealth.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Bausch Health Companies Inc.
Obesity Gold Rush To Drive Significant Spending Growth Through Decade, IQVIA Says
IQVIA’s latest usage and spending trends report forecasts US obesity market will grow to $35bn by 2028, while the two leading GLP-1 agonists have already posted eye-popping sales growth.
Drug Promotion: Sponsors Are Running Afoul Of US FDA’s CFL Guidance
Recent Office of Prescription Drug Promotion enforcement letters provide several learnings, including the need to be aware of a product’s regulatory history and competitive landscape when developing promotions that are consistent with FDA-labeling, experts said.
Bausch + Lomb’s Prescription For Consumer Health Sales Growth Includes ‘Benefit’ From Rx Drugs
Blink NutriTears supplement containing lutein/zeaxanthin, curcumin and vitamin D3 coming in 2024 is example of a cross-segment sales benefit B+L sees in dry eye product category. Consumer eye care and vision health product sales are key drivers for 18% Q1 net sales growth to $1.1bn.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
Company Information
- Industry
- Medical Devices
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- AB Sanitas
- Afexa Life Sciences Inc.
- Amoun Pharmaceutical
- Aton Pharma, Inc.
- Bausch Health Ireland Limited
- Bausch + Lomb Holding International
- Biovail Corporation
- Callisto Pharmaceuticals, Inc. Dendreon Corporation
- Dermik Laboratories, Inc.
- Dow Pharmaceutical Sciences, Inc.
- Eyetech Inc.
- Graceway Pharmaceuticals, LLC
- ICN Pharmaceuticals, Inc.
- iNova Diagnostics, Inc.
- Instituto Terapeutico Delta Ltda
- Medicis Aesthetics Holdings Inc
- Medicis Pharmaceutical Corporation
- Mercury (Cayman) Holdings
- OraPharma, Inc.
- Ortho Dermatologics
- Prestwick Pharmaceuticals, Inc.
- PharmaSwiss S.A.
- Pedinol Pharmacal, Inc.
- Salix Pharmaceuticals Ltd. (InKine Pharmaceutical
- Oceana Therapeutics, LLC
- Q-Med Scandinavia, Inc.
- Santarus, Inc.)
- Sanitas AB
- Solta Medical, Inc.
- SPI Pharmaceuticals Inc
- Synergetics USA, Inc.
- Synergy Pharmaceuticals Inc.(SGYP)
- Technolas Perfect Vision GmbH (TPV)
- Ucyclyd Pharma, Inc.
- Unilens Vision, Inc.
- Viratek Pharma Inc
- Valeant Pharmaceuticals International, Inc.
- Xcel Pharmaceuticals, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice